Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala

Journal of Neurophysiology

Volumn 97, Issue 6, 2007, Pages 3893-3904

  Ji, Guangchen ^a   Neugebauer, Volker ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; ASTRESSIN 2B; CARRAGEENAN; CORTICOTROPIN RELEASING FACTOR 1 ANTAGONIST; CORTICOTROPIN RELEASING FACTOR 2 ANTAGONIST; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; KAOLIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EVOKED CORTICAL RESPONSE; EXTRACELLULAR MATRIX; KNEE; KNEE ARTHRITIS; MALE; MECHANICAL STIMULATION; MICRODIALYSIS; MOLECULAR PROBE; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ACTION POTENTIALS; AMYGDALA; ANILINE COMPOUNDS; ANIMALS; ARTHRITIS; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; NEURAL INHIBITION; NEURONS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PEPTIDE FRAGMENTS; PHYSICAL STIMULATION; PYRIMIDINES; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TIME FACTORS;

EID: 34250669398     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00135.2007     Document Type: Article

References (71)

1. Arzt E, Holsboer F. CRF signaling: molecular specificity for drug targeting in the CNS. Trends Pharmacol Sci 27: 531-538, 2006.
2. Asan E, Yilmazer-Hanke DM, Eliava M, Hantsch M, Lesch KP, Schmitt A. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131: 953-967, 2005.
3. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-557, 2004.
4. Bird GC, Lash LL, Han JS, Zou X, Willis WD, Neugebauer V. Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones. J Physiol 564: 907-921, 2005.
5. Blank T, Nijholt I, Grammatopoulos DK, Randeva HS, Hillhouse EW, Spiess J. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J Neurosci 23: 700-707, 2003.
6. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17: 166-172, 1996.
7. Charney DS. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr Scand 108, Suppl. 417: 38-50, 2003.
8. Chen C, Dagnino R Jr, De Souza EB, Grigoriadis DE, Huang CQ, Kim KI, Liu Z, Moran T, Webb TR, Whitten JP, Xie YF, McCarthy JR. Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists. J Med Chem 39: 4358-4360, 1996.
9. Cui XY, Lundeberg T, Yu LC. Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in rats. Brain Res 995: 23-28, 2004.
10. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23: 71-77, 2002.
11. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 5: 565-575, 2004.
12. Gallagher RM, Verma S. Mood and anxiety disorders in chronic pain. Prog Pain Res Manage 27: 139-178, 2004.
13. Gauriau C, Bernard J-F. Pain pathways and parabrachial circuits in the rat. Exp Physiol 87: 251-258, 2002.
14. Gauriau C, Bernard J-F. A comparative reappraisal of projections from the superficial laminae of the dorsal horn in the rat: the forebrain. J Comp Neurol 468: 24-56, 2004.
15. Gray TS. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann NY Acad Sci 697: 53-60, 1993.
16. Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil 17: 415-422, 2005.
17. Greenwood-Van MeerveldB, Johnson AC, Schulkin J, Myers DA. Long-term expression of corticotropin-releasing factor (CRF) in the paraventricular nucleus of the hypothalamus in response to an acute colonic inflammation. Brain Res 1071: 91-96, 2006.
18. Han JS, Bird GC, Li W, Neugebauer V. Computerized analysis of audible and ultrasonic vocalizations of rats as a standardized measure of pain-related behavior. Neurosci Methods 141: 261-269, 2005a.
19. Han JS, Bird GC, Neugebauer V. Enhanced group III mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala. Neuropharmacology 46: 918-926, 2004.
20. Han JS, Fu Y, Bird GC, Neugebauer V. Enhanced group II mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala [Abstract]. Mol Pain 2: 18, 2006.
21. Han JS, Li W, Neugebauer V. Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. J Neurosci 25: 10717-10728, 2005b.
22. Han JS, Neugebauer V. mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain. Pain 113: 211-222, 2005.
23. Heinricher MM, McGaraughty S. Pain-modulating neurons and behavioral state. In: Handbook of Behavioral State Control, edited by Lydic R, Baghdoyan HA. New York: CRC Press, 1999, p. 487-503.
24. Ikeda H, Kusudo K, Ryu PD, Murase K. Effects of corticotropin-releasing factor on plasticity of optically recorded neuronal activity in the substantia gelatinosa of rat spinal cord slices. Pain 106: 197-207, 2003.
25. Ikeda R, Takahashi Y, Inoue K, Kato F. NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain. Pain 127: 161-172, 2007.
26. Kash TL, Winder DG. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51: 1013-1022, 2006.
27. Kirby LG, Rice KC, Valentino RJ. Effects of corticotropin- releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22: 148-162, 2000.
28. Kunzel HE, Ising M, Zobel AW, Nickel T, Ackl N, Sonntag A, Holsboer F, Uhr M. Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression. J Psychiatr Res 39: 173-177, 2005.
29. Lariviere WR, Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain 84: 1-12, 2000.
30. Li C, Vaughan J, Sawchenko PE, Vale WW. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22: 991-1001, 2002.
31. Li W, Neugebauer V. Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain. Pain 110: 112-122, 2004a.
32. Li W, Neugebauer V. Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons. J Neurophysiol 91: 13-24, 2004b.
33. Li W, Neugebauer V. Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain. J Neurophysiol 96: 1803-1815, 2006.
34. Maren S. Synaptic mechanisms of associative memory in the amygdala. Neuron 47: 783-786, 2005.
35. Martinez V, Wang L, Million M, Rivier J, Tache Y. Urocortins and the regulation of gastrointestinal motor function and visceral pain. Peptides 25: 1733-1744, 2004.
36. McNally GP, Akil H. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience 112: 605-617, 2002.
37. Meagher MW, Arnau RC, Rhudy JL. Pain and emotion: effects of affective picture modulation. Psychosom Med 63: 79-90, 2001.
38. Merchenthaler I, Vigh S, Petrusz P, Schally AV. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 165: 385-396, 1982.
39. Million M, Wang L, Wang Y, Adelson DW, Yuan PQ, Maillot C, Coutinho SV, McRoberts JA, Bayati A, Mattsson H, Wu V, Wei JY, Rivier J, Vale W, Mayer EA, Tache Y. CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut 55: 172-181, 2006.
40. Min SS, Han JS, Kim YI, Na HS, Yoon YW, Hong SK, Han HC. A novel method for convenient assessment of arthritic pain in voluntarily walking rats. Neurosci Lett 308: 95-98, 2001.
41. Miyata M, Okada D, Hashimoto K, Kano M, Ito M. Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression. Neuron 22: 763-775, 1999.
42. Mousa SA, Bopaiah CP, Stein C, Schafer M. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 106: 297-307, 2003.
43. Myers DA, Gibson M, Schulkin J, Greenwood Van-Meerveld B. Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity. Behav Brain Res 161: 39-44, 2005.
44. Neugebauer V. Subcortical processing of nociceptive information: basal ganglia and amygdala. Clin Neurol 81: 141-158, 2006.
45. Neugebauer V, Li W. Processing of nociceptive mechanical and thermal information in central amygdala neurons with knee-joint input. J Neurophysiol 87: 103-112, 2002.
46. Neugebauer V, Li W. Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain. J Neurophysiol 89: 716-727, 2003.
47. Neugebauer V, Li W, Bird GC, Bhave G, Gereau RW. Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5. J Neurosci 23: 52-63, 2003.
48. Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist 10: 221-234, 2004.
49. Paré D, Quirk GJ, Ledoux JE. New vistas on amygdala networks in conditioned fear. J Neurophysiol 92: 1-9, 2004.
50. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1998.
51. Pedersen LH, Scheel-Kruger J, Blackburn-Munro G. Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 127: 17-26, 2007.
52. Phelps EA, Ledoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48: 175-187, 2005.
53. Pollandt S, Liu J, Orozco-Cabal L, Grigoriadis DE, Vale WW, Gallagher JP, Shinnick-Gallagher P. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur J Neurosci 24: 1733-1743, 2006.
54. Price JL. Comparative aspects of amygdala connectivity. In: The Amygdala in Brain Function. Basic and Clinical Approaches, edited by Shinnick-Gallagher P, Pitkanen A, Shekhar A, Cahill L. New York: The New York Academy of Sciences, 2003, p. 50-58.
55. Rebaudo R, Melani R, Balestrino M, Izvarina N. Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices. Brain Res 922: 112-117, 2001.
56. Reul JM, Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2: 23-33, 2002.
57. Rhudy JL, Meagher MW. The role of emotion in pain modulation. Curr Opin Psychiatry 14: 241-245, 2001.
58. Rhudy JL, Meagher MW. Negative affect: effects on an evaluative measure of human pain. Pain 104: 617-626, 2003.
59. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Tache Y, Vale W. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45: 4737-4747, 2002.
60. Rizvi TA, Ennis M, Behbehani MM, Shipley MT. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J Comp Neurol 303: 121-131, 1991.
61. Rome HP Jr, Rome JD. Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Med 1: 7-23, 2000.
62. Sanchez MM, Young LJ, Plotsky PM, Insel TR. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 408: 365-377, 1999.
63. Siggins GR, Gruol D, Aldenhoff J, Pittman Q. Electrophysiological actions of corticotropin-releasing factor in the central nervous system. Fed Proc 44: 237-242, 1985.
64. Sinniger V, Porcher C, Mouchet P, Juhem A, Bonaz B. c-fos and CRF receptor gene transcription in the brain of acetic acid-induced somato-visceral pain in rats. Pain 110: 738-750, 2004.
65. Skelton KH, Owens MJ, Nemeroff CB. The neurobiology of urocortin. Regul Pept 93: 85-92, 2000.
66. Steckler T, Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46: 1480-1508, 1999.
67. Takahashi LK. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci Biobehav Rev 25: 627-636, 2001.
68. Tanimoto S, Nakagawa T, Yamauchi Y, Minami M, Satoh M. Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci 18: 2343-2350, 2003.
69. Ulrich-Lai YM, Xie W, Meij JTA, Dolgas CM, Yu L, Herman JP. Limbic and HPA axis function in an animal model of chronic neuropathic pain. Physiol Behav 88: 67-76, 2006.
70. Vit JP, Clauw DJ, Moallem T, Boudah A, Ohara PT, Jasmin L. Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats. Pain 121: 241-260, 2006.
71. Zobel AW, Nickel T, Kunzel HE, Ackl N, Sonntag A, Ising M, Holsboer F. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 34: 171-181, 2000.